Enhanced expression of salusin-β contributes to progression of atherosclerosis in LDL receptor deficient mice

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 4, 2012, Pages 463-471

  Zhou, Cheng Hua ^a   Liu, Lan Lan ^a   Wu, Yu Qing ^a   Song, Zheng ^a   Xing, Shu Hua ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Mice; Peptide; Salusin

Indexed keywords

CHOLESTEROL; EOSIN; HEMATOXYLIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PEPTIDE; SALUSIN BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; CHOLESTEROL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; PROTEIN PRECURSORS; RECEPTORS, LDL;

EID: 84859148904     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-022     Document Type: Article

References (18)

1. Ishigaki, Y., Katagiri, H., Gao, J., Yamada, T., Imai, J., Uno, K., et al. 2008. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation, 118(1): 75-83. doi:10.1161/CIRCULATIONAHA.107.745174. PMID:18559699.
2. Izumiyama, H., Tanaka, H., Egi, K., Sunamori, M., Hirata, Y., and Shichiri, M. 2005. Synthetic salusins as cardiac depressors in rat. Hypertension, 45(3): 419-425. doi:10.1161/01.HYP.0000156496.15668.62. PMID:15699450.
3. Little, P.J., Ballinger, M.L., and Osman, N. 2007. Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis. Vasc. Health Risk Manag. 3(1): 117-124.PMID:17583182.
4. Nagashima, M., Watanabe, T., Shiraishi, Y., Morita, R., Terasaki, M., Arita, S., et al. 2010. Chronic infusion of salusin-alpha and-beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis, 212(1): 70-77.doi:10.1016/j.atherosclerosis.2010.04.027. PMID:20684826.
5. Saito, T., Dayanithi, G., Saito, J., Onaka, T., Urabe, T., Watanabe, T. X., et al. 2008. Chronic osmotic stimuli increase salusin-beta-like immunoreactivity in the rat hypothalamo-neurohypophyseal system: possible involvement of salusin-beta on [Ca2+]i increase and neurohypophyseal hormone release from the axon terminals. J. Neuroendocrinol. 20(2): 207-219. doi:10.1111/j.1365-2826.2007.01632.x. PMID:18047553.
6. Santos, M.G., Pegoraro, M., Sandrini, F., and Macuco, E.C. 2008. Risk factors for the development of atherosclerosis in childhood and adolescence. Arq. Bras. Cardiol. 90(4): 276-283.PMID:18516390.
7. Sato, K., Koyama, T., Tateno, T., Hirata, Y., and Shichiri, M. 2006. Presence of immunoreactive salusin-alpha in human serum and urine. Peptides, 27(11): 2561-2566. doi:10.1016/j.peptides.2006.06.005. PMID:16889872.
8. Sato, K., Sato, T., Susumu, T., Koyama, T., and Shichiri, M. 2009. Presence of immunoreactive salusin-beta in human plasma and urine. Regul. Pept. 158(1-3): 63-67. doi:10.1016/j.regpep.2009.07.017. PMID:19660505.
9. Shichiri, M., Ishimaru, S., Ota, T., Nishikawa, T., Isogai, T., and Hirata, Y. 2003. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat. Med. 9(9): 1166-1172. doi:10.1038/nm913. PMID:12910263
10. Suzuki, N., Shichiri, M., Akashi, T., Sato, K., Sakurada, M., Hirono, Y., et al. 2007. Systemic distribution of salusin expression in the rat. Hypertens. Res. 30(12): 1255-1262. doi:10.1291/hypres.30.1255. PMID:18344632.
11. Takenoya, F., Hori, T., Kageyama, H., Funahashi, H., Takeuchi, M., Kitamura, Y., et al. 2005. Coexistence of salusin and vasopressin in the rat hypothalamo-hypophyseal system. Neurosci. Lett. 385 (2): 110-113. doi:10.1016/j.neulet.2005.05.061. PMID:15961227.
12. Ti, Y., Wang, F., Wang, Z.H., Wang, X.L., Zhang, W., Zhang, Y., and Bu, P.2011. Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction inssential hypertension. J. Hum. Hypertens., In press. doi:10.1038/jhh.2011.71. PMID:21833023.
13. Watanabe, T., Nishio, K., Kanome, T., Matsuyama, T.A., Koba, S., Sakai, T., et al. 2008a. Impact of salusin-alpha and-beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation, 117(5): 638-648. doi:10.1161/CIRCULATIONAHA.107.712539. PMID:18212280.
14. Watanabe, T., Suguro, T., Sato, K., Koyama, T., Nagashima, M., Kodate, S., et al. 2008b. Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens. Res. 31(3): 463-468. doi:10.1291/hypres.31.463. PMID:18497465.
15. Watanabe, T., Sato, K., Itoh, F., Iso, Y., Nagashima, M., Hirano, T., and Shichiri, M. 2011. The roles of salusins in atherosclerosis and related cardiovascular diseases. J. Am. Soc. Hypertens. 5(5): 359-365. doi:10.1016/j.jash.2011.06.003. PMID:21925457.
16. Wu, Y., Zhang, R., Zhou, C., Xu, Y., Guan, X., Hu, J., et al. 2009. Enhanced expression of vascular cell adhesion molecule-1 by corticotrophin-releasing hormone contributes to progression of atherosclerosis in LDL receptor-deficient mice. Atherosclerosis, 203(2): 360-370. doi:10.1016/j.atherosclerosis.2008.05.059.PMID:18640679.
17. Xiao-Hong, Y., Li, L., Yan-Xia, P., Hong, L., Wei-Fang, R., Yan, L., et al. 2006. Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78. J. Cardiovasc. Pharmacol. 48(2): 41-46. doi:10.1097/01.fjc.0000242059.89430.ac. PMID:16954820.
18. Yu, F., Zhao, J., Yang, J., Gen, B., Wang, S., Feng, X., et al. 2004. Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul. Pept. 122(3): 191-197. doi:10.1016/j.regpep.2004.06.013. PMID:15491791.